Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Stintzing

Showing results (101-110 of 206) with videos related to

Pageof 21
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 17, 2018
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trialMitsukuni Suenaga, Sebastian Stintzing, Shu Cao, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 16, 2020
Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological SocietyUlrike Irmgard Attenberger, Stephan Clasen, Michael Ghadimi, et al.
Cancers|November 11, 2022
Radiofrequency Electromagnetic Fields Cause Non-Temperature-Induced Physical and Biological Effects in Cancer CellsPeter Wust, Paraskevi D Veltsista, Eva Oberacker, et al.
Cancer|February 19, 2015
Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastasesStefan Stremitzer, Wu Zhang, Dongyun Yang, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2020
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trialsArndt Stahler, Volker Heinemann, Ingrid Ricard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2016
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based ChemotherapySatoshi Matsusaka, Diana L Hanna, Shu Cao, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
Frontiers in Oncology|August 13, 2021
Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 StudyJana Käthe Striefler, Hanno Riess, Philipp Lohneis, et al.
Cell Death and Differentiation|April 9, 2025
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
European Radiology|May 9, 2018
Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastasesKatharina S Winter, Felix O Hofmann, Kolja M Thierfelder, et al.
Pageof 21

Showing results (101-110 of 206) with videos related to

Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|December 17, 2018
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trialMitsukuni Suenaga, Sebastian Stintzing, Shu Cao, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 16, 2020
Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological SocietyUlrike Irmgard Attenberger, Stephan Clasen, Michael Ghadimi, et al.
Cancers|November 11, 2022
Radiofrequency Electromagnetic Fields Cause Non-Temperature-Induced Physical and Biological Effects in Cancer CellsPeter Wust, Paraskevi D Veltsista, Eva Oberacker, et al.
Cancer|February 19, 2015
Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastasesStefan Stremitzer, Wu Zhang, Dongyun Yang, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2020
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trialsArndt Stahler, Volker Heinemann, Ingrid Ricard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2016
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based ChemotherapySatoshi Matsusaka, Diana L Hanna, Shu Cao, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
Frontiers in Oncology|August 13, 2021
Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 StudyJana Käthe Striefler, Hanno Riess, Philipp Lohneis, et al.
Cell Death and Differentiation|April 9, 2025
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
European Radiology|May 9, 2018
Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastasesKatharina S Winter, Felix O Hofmann, Kolja M Thierfelder, et al.
Pageof 21